Stock analysts at StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the ...
Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback